http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103360305-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-50 |
| filingDate | 2012-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103360305-B |
| titleOfInvention | Substituted aryl piperazine aralkyl ketone derivatives and preparing the application in analgesic |
| abstract | The invention discloses a kind of substituted aryl piperazine aralkyl ketone derivatives and preparing the application in analgesic, the substituted aryl piperazine aralkyl ketone derivatives that the present invention relates to and physiologically acceptable salt thereof, there is very useful pharmaceutical properties and good tolerance, especially as the application of new type analgesic thing.This compounds is non-addicted central analgesia agent, and animal experiment, without obvious sedative effect, has very little toxic side effect and higher safety index.Described substituted aryl piperazine aralkyl ketone derivatives is free alkali or the salt with following structure general formula; |
| priorityDate | 2012-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.